*To whom correspondence should be addressed: mchartman@vcu.edu Table S1 . Calculated and Observed MALDI-TOF m/z 2 S-Methionine incorporation. "-tRNA" corresponds to an assay with no precharged tRNA added to translation. "-ncAA" corresponds to an assay containing added tRNA that was pre-charged in the absence of the ncAA. The yield of the peptides was calculated using the radioactive counts of the capture peptide after subtraction of a background translation experiment lacking mRNA. Val DNA template construction. V-5 contains a 2' O-methylated guanine base ("mG") to reduce non-templated nucleotide addition at the 3' terminus of the DNA template to be used for tRNA transcription. [1] Name Sequence tRNA Val GUA  TGG TGG GTG ATG ACG GGA TCG AAC CGC CGA CCC CCT CCT TGT AAG GGA GGT GCT CTC CCA GCT GAG CTA  ATC ACC CTA TAG TGA GTC GTA TTA  T7 Forward  TAATACGACTCACTATAGGG   Table S4 . tRNA Val transcription primers for the AARS charging assay. Figure S1 . ncAAs Test for Aminoacylation by ValRS T222P. Figure S2 . Overview of AARS Charging Assay. The aminoacylated tRNA species is subjected to reductive amination at the free amino group of the amino acid with a triphenylphosonium benzaldehyde reagent. The resulting AA-tRNA-triphenylphosphonium species is digested with Nuclease P1 to yield an AA-AMP species easily detectable by MALDI-TOF. Figure S3 . MALDI-TOF MS AARS assay showing isotopic resolution. Charging Assay of each ncAA charged with ValRS T222P. The major peak in each assay corresponds to the derivatized amino acid. In certain cases small peaks from charging of valine are present (calc. 855.3031 Da). See Table S1 for expected masses. P charging assay charging assay to minimize background valine charging while maintaining activity for -1. Blue bars show the % AA-tRNA formed after 1 h reaction in the presence of 10 mM -1. Red bars represent identical assays in the absence of -1, and, therefore, represent background valine incorporation. Upon 10-fold dilution of the enzyme, the background valine contamination was reduced significantly, yet the ability to charge -1 was maintained, indicating that the valine source was the enzyme stock itself. Bars are indicative of singlet analysis. Table S1 for expected masses. The additional peaks at +137 are occasionally observed in His-rich templates and they are consistent with the sodium trifluoroacetate adduct of the protonated peptide [2] . In (C) the yields of each of the duplicate translation experiments is shown in comparison to a Valine control. and MeSer (B) into an mRNA template coding for peptide sequence MVTNPDCFGNPVCGGGHHHHHH. Peptides were cyclized with dibromoxylene at the two cysteine residues as previously described. 
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Materials/Methods
General procedures
Matrix-assisted laser desorption/ionization analysis was performed on an Applied Biosystems Voyager by using delayed extraction in reflector positive mode. All spectra were calibrated internally for the AARS screening assay to 756.2352 (the mass of the 4-formylphenoxypropyl triphenylphosphonium AMP derivative). Deacylation of tRNA was performed by dissolving E. coli total tRNA (100 mg/mL) (Sigma) in 1M Tris-HCl (pH 9.0), incubation at 37°C for 2 h followed by overnight dialysis against 50 mM Tris-HCl (pH 9.0). The tRNA was recovered by addition of 0.1 volume KOAc (3.0 M pH 5.5) and 4 volumes of cold 100% ethanol. After centrifugation, the tRNA pellet was washed twice with 70% cold ethanol and suspended in ddH20 at a concentration of 100 mg/mL, aliquoted and stored at -80°C. CCA tRNA nucleotidyltransferase was expressed as described [4] .
Sources of Amino Acids
Successful Analogs: α-methyl Serine (MP Biochemicals), α-methyl Alanine (Sigma), aminobutyric acid (Sigma), azidohomoalanine (gift from the Tirrell Lab at Cal Tech), β-cyano
All β amino acids were a gift from Dr. Sam Gellman (University of Wisconsin-Madison).
Synthesis of activated amino acids N-boc-L-valine (ChemImpex) and N-boc-L-cis-2-aminocyclohexanecarboxylic acid (ChemImpex) were activated with 3,5-dinitrobenzyl chloride (DNB) (Sigma-Aldrich) and deprotected as described [5] . In brief, 0.6 mmol of the amino acid and 0.5 mmol of DNB were added to a dry flask, dried under argon, and dissolved in a solution of dry triethylamine (1 mmol, 139 L) in DMF (500 L). The reaction was allowed to proceed under argon for 16 hours at rt. The reaction was then diluted with ether (45 mL) , washed with 0.5 M HCl (3 x 15 mL), saturated NaHCO3 (3 x 15 mL), and saturated NaCl (1 x 15 mL). The organic layer was extracted and dried with MgSO4 before concentration on a rotary evaporator. The resulting oil was incubated for 20 min in 3M HCl/ethyl acetate (3 mL) at rt and subsequently concentrated on a rotary evaporator. The product was washed with ether (3 x5 mL) and dried on a rotary evaporator. The final product was assessed for purity via 
ValRS T222P Expression and Purification
The ValRS T222P construct was made by digesting a pET24a vector containing the wild type ValRS with StuI and Eam1105I. The resulting linear plasmid was purified via 1% agarose gel electrophoresis and a commercially ordered gene fragment (see below) containing the T222P mutation was ligated into the linear plasmid using T4 DNA ligase. The resulting plasmid was verified using DNA sequencing (Eurofins), transformed into chemically competent BL21 E. coli cells, and grown overnight on ampicillin LB plates. Single colonies were picked and grown in an overnight 5 mL culture with ampicillin at 37°C. This starter culture was diluted 1:100 into fresh 200 mL LB media with ampicillin and grown to mid-log phase. Protein production was induced upon addition of 0.10 mM final concentration of IPTG and grown for 3 h at 37°C. Cells were pelleted and lysed with 10 mL of B-PER and 50 μL histidinetagged compatible protease inhibitor cocktail (Sigma P8849). The lysate was centrifuged at 15,000 rpm and the soluble fraction was applied to a pre-equilibrated Ni-NTA Agarose (McLab) column and allowed to bind for 1 h at 4°C. The column was washed with two 10 mL portions of wash buffer (20 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, 10 mM Mg(OAc)2, 5 mM BME), and eluted into 5 x 1 mL fractions of elution buffer (20 mM TrisHCl, 300 mM NaCl, 250 mM imidazole, 10 mM Mg(OAc)2, 5 mM BME). Fractions containing protein were pooled and dialyzed overnight into enzyme storage buffer (50 mM HEPES-KOH, 100 mM KCl, 10 mM MgCl2, 7 mM BME, 30% Glycerol). 2.5 μL of post dialysis protein was mixed with 2.5 μL of 2x SDS Lamelli Sample Buffer and was run on a 10% SDS-Page gel to verify molecular weight. 
Gene Fragment T222P Mutation
Valine depletion in ValRS T222P
To limit the contamination of valine purified with the ValRS T222P enzyme we first performed a mock tRNA pre-charging performed exactly as above but lacking any amino acid. The synthetase was then re captured on Ni-NTA resin and dialyzed into enzyme storage buffer.
MALDI-AARS Screening Assay Procedure
Each charging reaction contained 30 mM HEPES-KOH (pH 7.4), 15 mM MgCl2, 25 mM KCl, 2 mM 2-mercaptoethanol, 6 mM ATP, 0.09 mg/mL BSA (previously dialyzed into ddH2O), 0.02 units/μL PPiase, 350 μM deacylated tRNA, 5 μM ValRS T222P, 10 mM non-canonical amino acid, and ddH2O to a final volume of 50 μL. Each reaction was initiated by addition of ValRS T222P to the mixture and incubated for 30 minutes at 37°C. Each reaction was quenched by addition of 0.1 volume of NaOAc (3.0 M, pH 5.2) and tRNA was extracted with unbuffered phenol:chloroform:isoamyl alcohol solution (25:24:1). The aqueous layer was subjected to a second extraction with chloroform, followed by ethanol precipitation (3 vol.) with 0.1 volume NaOAc (3.0 M, pH 5.2). After centrifugation, the pellet was washed twice with 70% cold ethanol and resuspended in 200 mM NaOAc (pH 5.0) for use in AARS screening assay. tRNA for use in screening assay (6.75 μL) was added to water (3.75 μL), 30 mM (4-formylphenoxyproyl)triphenylphosphonium bromide in MeOH, 20 mM NaCNBH3 in 50 mM NaOAc (pH 5.0) and tumbled at 37°C for 2 h. The reaction was quenched with 0.1 volume 4.4 M NH4OAc pH 5.0 and 3 volumes of ice cold 100% EtOH, pelleted and washed twice with 70% EtOH and twice with 100% EtOH. The resulting pellet was resuspended in 2.25 μL 200 mM NH4OAc and digested with 0.25 μL of 1 U/μL of Nuclease P1 (in 200 mM NH4OAc, pH 5.0). After 20 minutes at room temperature, the reaction was quenched by placing on ice. One microliter was mixed with saturated CHCA (α-cyano-4-hydroxycinnamic acid) matrix in 1:1 MeCN:1% TFA (9 μL). One microliter of the resulting suspension was spotted on a MALDI plate and analyzed.
tRNA Pre-charging The MALDI-AARS screening assay procedure was followed up until the first ethanol precipitation step. The precipitated tRNA was then dissolved in 20 μL 5 mM KOAc (pH 5.5) and stored at -80 o C until use.
tRNA Val PCR and Purification DNA encoding for tRNA transcripts were prepared using PCR primers (Integrated DNA Technologies) from table S2. Primer extension was performed by mixing V-1 and V-2 (1 μM each) in Q5 polymerase buffer as per manufacture protocol (NEB M0491S) on a 10 μL scale. PCR was performed by denaturing (95°C for 1 min) following by annealing (50°C for 1 min) and extension (72°C for 1 min) for 5 cycles. The resulting PCR was diluted into 200 μL PCR buffer and amplified using V-3 and V-4 primers (95°C for 40 sec, 62°C for 40 sec, 72°C for 40 sec, 5 cycles). The final PCR was performed on a 1 mL scale (10 x 100 μL) using 5 μL of the previous PCR (95°C for 40 sec, 63°C for 40 sec, 72°C for 40 sec, 15 cycles). The final product was verified by 3% agarose gel analysis with ethidium bromide staining. The resulting DNA was purified by phenol/chloroform extraction followed by ethanol precipitation and dissolved in 50 μL water.
T7 Transcription
Transcription of tRNA was done by incubating the entirety of the PCR amplified DNA or synthetic template primers (Table S4 , 1 M each) in transcription buffer (40 mM Tris-HCl pH 7.8, 0.01% v/v Triton X-100, 2.5 mM spermidine, 25 mM MgCl2, 10 mM DDT, 5 mM each NTP, 5 mM GMP, 0.2 units/mL RNAsin, 1 U/mL PPi, 0.1 mg/mL T7 polymerase) on a 1 mL scale and incubated overnight at 37°C. The reaction was quenched by addition of 100 μL 0.5 M EDTA (pH 8.0) and 435 mg urea (8 M final concentration), heated to 90 o C for 5 minutes, and loaded onto and purified by a 10% denaturing urea page gel. The desired band was visualized by UV shadowing, extracted by crushing and soaking in 0.3 M NaCl or electroelution followed by ethanol precipitation. Activity of tRNA was verified by performing a charging assay with transcribed tRNA, wild type ValRS, and valine. A slightly modified protocol was used for T7 transcription of dFx as described [6] . 32 P-labeling of tRNA using CCA tRNA nucleotidyl transferase
The 3' end of tRNA was labeled with 32 P ( 32 P-ATP, Perkin Elmer) in 100 L reactions as described [7] . The tRNA was purified by extraction in 1 volume of 25:24:1 buffered phenol:chloroform:isoamyl alcohol. The mixture was vortexed and centrifuged for 1 min at 13000 rpm. The aqueous layer was then added to 1.1 volumes of chloroform, vortexed, and centrifuged. The aqueous layer was loaded onto a NAP-5 column (GE Healthcare) preequilibrated with water, followed by addition of 400 L of water. Labeled tRNA was eluted with 500 L of water into a clean microcentrifuge tube. The eluent was added to a PL-10 centricon (Millipore) and centrifuged at 14000 rpm for 30min, pausing at 15 min to ensure the membrane had not dried out. The membrane was then washed with 250 L of water and centrifuged at 14000 rpm for 30 min. The filter was then removed, inverted on a clean microcentrifuge tube, and eluted by centrifugation at max speed for 1 min. 1 L of the product was removed for analysis of radioactivity via scintillation counting. The remainder was stored in an acrylic shielded box at -20C.
P Charging Assay using ValRS T222P
Aminoacylation of tRNA Val with ValRS T222P was adapted from Wolfson and Uhlenbeck [7] . 20 L reactions containing 30 mM HEPES-KOH (pH 7.4), 20 M unlabeled tRNA Val GUA, 25000 cpm 32 P-labeled tRNA Val GUA, 15 mM MgCl2, 25 mM KCl, 2 mM ATP, 0.09mg/mL dialyzed BSA, 100 M L-valine or 10 mM L-cis-2-aminocyclohexanecarboxylic acid, and 156 nM ValRS T222P were prepared. Water, HEPES buffer, and the tRNA species were added to a 96-well plate, heated to 95C for 3 min, and cooled to 25C at a rate of 0.2C/s. MgCl2, KCl, ATP, and BSA were added and the reaction was heated for 5 minutes at 25C and then placed on ice. The amino acids and synthetase were added to the ValRS reaction and incubated at 37C. At 0, 2, 5, 20, 60, and 120 minutes, 1 L of each reaction was removed and added to 4 L of 0.1U/L Nuclease P1 (Wako) in 200mM NaOAc (pH 5) and kept on ice. Once the final timepoint was collected, the nuclease reactions were incubated for 10 minutes at 25C. 1 L of each well was then spotted on 10 cm tall PEI cellulose plates (Sigma) pre-run in water and allowed to dry. The plates were run in 5:10:85 acetic acid:saturated boric acid:water, allowed to dry, and wrapped in saran wrap before exposure to a phosphorimaging screen (GE Healthcare and Life Sciences) overnight. The screen was imaged on a GE Typhoon 9410 scanner and the ratio of aminoacylated tRNA to nonacylated tRNA was quantified using density analysis on ImageQuant5. Reactions were run in duplicate. 32 P Charging Assay using dFx 20 L reactions containing a final concentrations of 200 mM HEPES-KOH (pH 7.5), 20 M tRNA Val GUA, 25000 cpm labeled tRNA Val GUA, 0.6 M MgCl2, 20 M dFx, and 5 mM DNB-valine or 10 mM DNB-cis-2-aminocyclohexanecarboxylic acid were prepared. Water, HEPES buffer, and the tRNA species were added to a 96-well plate, heated to 95C for 3 min, and cooled to 25C at a rate of 0.2C/s. MgCl2 and dFx were added to the flexizyme reactions, and the reactions were incubated for 5 minutes at 25C and then placed on ice. Activated amino acids were added to the flexizyme reaction and allowed to proceed on ice. At 0, 2, 5, 20, 60, and 120 minutes, 1 L of each reaction was removed and added to 4 L of 0.1U/L Nuclease P1 (Wako) in 20 0mM NaOAc (pH 5) and kept on ice. The nuclease reaction and subsequent analysis are as above.
Mutant Ribosome Isolation
A plasmid containing a mutant 23S ribosome subunit in a pLK35 vector (gifted by Shepeartz Lab, Yale University) was transformed into RNAse deficient A19 strain of E. coli. A 2 mL starter culture was diluted 1:5000 into 1 L of LB and grown to OD 0.60 at 37 o C followed by 2 hours at 42 o C for induction of the λ PL promoter in the pLK35 plasmid. From here, ribosome isolation was performed as previously reported. [8] 
